Latest News & Updates

Breaking News

  • 1 hour ago

  • Vaibhavi M.

Intelligent Bio Solutions Starts Clinical Program For FDA Clearance Of Codeine Test, Launches Trials With Cliantha To Support U.S. Market Clearance
Breaking News
Immix Biopharma’s CAR-T Candidate NXC-201 Earns FDA Breakthrough Therapy Designation In Relapsed AL Amyloidosis

Vaibhavi M.

FDA Grants Breakthrough Status To Biogen’s Litifilimab For Treatment Of Cutaneous Lupus Erythematosus (CLE)

Vaibhavi M.

Chugai Seeks Japanese Approval For Tecentriq, Phase III IMvigor011 Data Supports Filing In MRD-Positive Muscle-Invasive Bladder Cancer

Vaibhavi M.

Siren Biotechnology Becomes Clinical-Stage Company As FDA Approves IND For Its AAV-Based Cancer Therapy Targeting Recurrent High-Grade Glioma

Simantini Singh Deo

Other trending news you may like to read

Intelligent Bio Solutions Starts Clinical Program For FDA Clearance Of Codeine Test, Launches Trials With Cliantha To Support U.S. Market Clearance

Intelligent Bio begins clinical studies to support a new FDA 510(k) submission for its fingerprint-based codeine drug test.

Vaibhavi M.

Pharma Now

Immix Biopharma’s CAR-T Candidate NXC-201 Earns FDA Breakthrough Therapy Designation In Relapsed AL Amyloidosis

Immix Biopharma’s CAR-T therapy NXC-201 receives FDA Breakthrough designation for relapsed/refractory AL amyloidosis.

Vaibhavi M.

Pharma Now

FDA Grants Breakthrough Status To Biogen’s Litifilimab For Treatment Of Cutaneous Lupus Erythematosus (CLE)

Biogen’s litifilimab receives FDA Breakthrough Therapy Designation for cutaneous lupus, addressing a major unmet need.

Vaibhavi M.

Pharma Now

Chugai Seeks Japanese Approval For Tecentriq, Phase III IMvigor011 Data Supports Filing In MRD-Positive Muscle-Invasive Bladder Cancer

Chugai seeks Japan approval to use Tecentriq as adjuvant therapy for MRD-positive muscle-invasive bladder cancer patients.

Vaibhavi M.

Pharma Now